37 of 40
BACK NEXT
FOREIGN VALUE: Sanofi-Aventis
Ticker: SNY
Market cap (billions): $96.4
P/E ratio*: 13
Earnings growth**: 4.5%
Dividend yield: 3.1%

Paris-based Sanofi-Aventis is the largest pharmaceutical company in Europe. It has invested heavily in research and development on cardiovascular and diabetes drugs, which has paid off. Sanofi's top drugs include blood-clot treatment Lovenox, blood thinner Plavix and insulin drug Lantus.

While the company's earnings are expected to increase about 4.5% a year for the next few years as it - along with other drugmakers - sees some medications go off patent, this is more than reflected in the stock price. It trades at only 13 times earnings. Plus, it pays a healthy dividend that yields more than 3%.

NEXT: FOREIGN VALUE: Total
Last updated June 20 2008: 2:35 PM ET
Criteria include low price/earnings and price/book ratios relative to competitors, rising profit margins, and accelerating earnings growth.
*Based on previous 12-months' reported earnings. **Wall Street estimates for the next three years.
Source: Zacks Investment Research
Fortune 40: Full list A complete list of all 40 stocks, with live financial data. (more)
Ultimate mutual fund portfolioIf you crave diversification, stability, and results - but you'd rather leave the hard work to a savvy pro - this collection is for you. (more)
6 real estate bargains The housing downturn's upside? You don't have to go overseas anymore for your dream retirement home. We found the six best markets for deals. (more)

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer. Morningstar: © 2018 Morningstar, Inc. All Rights Reserved. Factset: FactSet Research Systems Inc. 2018. All rights reserved. Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2018 and/or its affiliates.